Cancer Clinical Trials
icon of a microscope overlayed on an image of cancer cells

Minnesota Cancer Clinical Trials Network

Nearly half of all Minnesotans will be diagnosed with a potentially life-threatening cancer during their lifetimes; one out of four Minnesotans die of cancer, and cancer is the leading cause of death in our state. To impact these grim statistics, local healthcare providers need equitable knowledge of cutting edge cancer research as well as access to the full menu of options for patient care.


Funded through the MnDRIVE initiative, the Minnesota Cancer Clinical Trials Network (MNCCTN) is a multi-site cancer clinical trials network with locations across the state. Led by the Masonic Cancer Center, University of Minnesota, the MNCCTN is made up of several partner organizations that aim to improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention and treatment.

Benefits to expanded access include:

  • Providing doctors with equitable knowledge of and access to new treatment options to enhance their understanding of the disease and increase options for patient care
  • Improving patient outcomes by increased participation in clinical trials
  • Decreasing the burden of cancer on Minnesotans by engaging a broader population in clinical research